Literature DB >> 15338315

Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study.

L S Cohen1, R M Nonacs, J W Bailey, A C Viguera, A M Reminick, L L Altshuler, Z N Stowe, S V Faraone.   

Abstract

OBJECTIVE: Pregnancy has frequently been referred to as a time of emotional well-being for patients. However, systematic data about the risk for relapse of depression during pregnancy are sparse.
METHOD: We completed a longitudinal cohort study of thirty-two (N = 32) women with histories of depression who were euthymic at conception and who either discontinued or attempted to discontinue antidepressant therapy proximate to conception. Subjects were prospectively followed across pregnancy once per trimester using structured clinical interviews. Rates of relapse and time to relapse were examined. Factors distinguishing the population with respect to risk for relapse including demographic characteristics and illness history were also examined.
RESULTS: Seventy-five percent (N = 24) of patients relapsed during pregnancy. The majority of relapses (79%, N = 19) occurred in the first trimester, and relapse was more prevalent in women with histories of more chronic depression.
CONCLUSIONS: Pregnancy is not "protective" with respect to risk for relapse of depression. Careful treatment planning is necessary for those women on antidepressants who plan to conceive or who become pregnant.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15338315     DOI: 10.1007/s00737-004-0059-3

Source DB:  PubMed          Journal:  Arch Womens Ment Health        ISSN: 1434-1816            Impact factor:   3.633


  19 in total

1.  Family history, not lack of medication use, is associated with the development of postpartum depression in a high-risk sample.

Authors:  Mary Kimmel; Edward Hess; Patricia S Roy; Jennifer Teitelbaum Palmer; Samantha Meltzer-Brody; Jennifer M Meuchel; Emily Bost-Baxter; Jennifer L Payne
Journal:  Arch Womens Ment Health       Date:  2014-07-01       Impact factor: 3.633

2.  A case report of the use of vilazodone in pregnancy.

Authors:  Caroline M Morrison
Journal:  Prim Care Companion CNS Disord       Date:  2014

Review 3.  Selective serotonin reuptake inhibitors and pregnancy: A review of maternal, fetal and neonatal risks and benefits.

Authors:  Zbigniew Marchocki; Noirin E Russell; Keelin O' Donoghue
Journal:  Obstet Med       Date:  2013-08-08

Review 4.  Antidepressant use during pregnancy: current controversies and treatment strategies.

Authors:  Jennifer L Payne; Samantha Meltzer-Brody
Journal:  Clin Obstet Gynecol       Date:  2009-09       Impact factor: 2.190

5.  DNA methylation in neonates born to women receiving psychiatric care.

Authors:  James W Schroeder; Alicia K Smith; Patricia A Brennan; Karen N Conneely; Varun Kilaru; Bettina T Knight; D Jeffrey Newport; Joseph F Cubells; Zachary N Stowe
Journal:  Epigenetics       Date:  2012-04-01       Impact factor: 4.528

6.  Recent Advances and Controversies in Peripartum Depression.

Authors:  Jennifer L Payne
Journal:  Curr Obstet Gynecol Rep       Date:  2016-07-01

7.  Maternal treatment with P7C3-A20 protects from impaired maternal care after chronic gestational stress.

Authors:  Rachel Schroeder; Lynn Nguyen; Andrew A Pieper; Hanna E Stevens
Journal:  Behav Brain Res       Date:  2021-08-25       Impact factor: 3.332

Review 8.  [Affective disorders during pregnancy : Therapy with antidepressants and mood stabilizers].

Authors:  N Bergemann; W E Paulus
Journal:  Nervenarzt       Date:  2016-09       Impact factor: 1.214

Review 9.  Selective Serotonin Reuptake Inhibitor Use during Pregnancy and the Risk of Autism Spectrum Disorders: A Review.

Authors:  Takoua Boukhris; Anick Bérard
Journal:  J Pediatr Genet       Date:  2015-06

Review 10.  Perinatal depression: treatment options and dilemmas.

Authors:  Teri Pearlstein
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.